CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA

ConclusionsPolymorphic variations of CALCA and TRPV1 genes might play a role as prognostic markers of efficacy of OnabotulinumtoxinA in chronic migraine female patients in our population.

http://link.springer.com/10.1186/s10194-019-0989-9

Source: The Journal of Headache and Pain - April 22, 2019 Category: Neurology Source Type: research